Sylogist Ltd. (TSE:SYZ - Free Report) - Cormark decreased their FY2025 earnings estimates for Sylogist in a report issued on Friday, May 16th. Cormark analyst G. Fairweather now anticipates that the company will post earnings per share of $0.03 for the year, down from their prior forecast of $0.09. The consensus estimate for Sylogist's current full-year earnings is $0.24 per share.
Sylogist Stock Performance
SYZ traded down C$0.32 during midday trading on Monday, reaching C$8.97. The company had a trading volume of 5,727 shares, compared to its average volume of 48,117. The company has a debt-to-equity ratio of 47.19, a quick ratio of 0.51 and a current ratio of 0.54. The stock has a market cap of C$212.10 million, a PE ratio of 199.06 and a beta of 0.82. Sylogist has a 12-month low of C$6.33 and a 12-month high of C$11.60. The business has a 50-day moving average price of C$8.51 and a two-hundred day moving average price of C$9.27.
Sylogist Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 12th. Shareholders of record on Wednesday, March 12th were paid a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.45%. The ex-dividend date of this dividend was Friday, February 28th. Sylogist's payout ratio is 88.77%.
Sylogist Company Profile
(
Get Free Report)
Sylogist Ltd., a software company, provides mission-critical software-as-a-service solutions in Canada, the United States, and the United Kingdom. The company offers SylogistMission constituent relationship management system, which includes donor management, fundraising, volunteer management, and program delivery; and enterprise resource management, such as accounting and financial management, grant and award management, budget management, payroll and human resources, analytics and reporting, and support and training.
Featured Stories
Before you consider Sylogist, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sylogist wasn't on the list.
While Sylogist currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
